Table of Content

Part 1. Introduction
1.1 Market Definition
1.2 Key Benefit
1.3 Market Segment
Part 2. Methodology
2.1 Primary
2.2 Secondary
Part 3. Executive Summary

Part 4. Market Overview
4.1 Introduction
4.2 Market Size and Forecast
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.4 Impact of COVID-19 Pandemic

Part 5. Global Market for Pain Management Drugs by Drug Class
5.1 Anesthetics
5.1.1 Market Size and Forecast
5.2 Anticonvulsant
5.2.1 Market Size and Forecast
5.3 Antidepressant Drugs
5.3.1 Market Size and Forecast
5.4 Antimigraine Drug
5.4.1 Market Size and Forecast
5.5 Non-Narcotic Analgesics
5.5.1 Market Size and Forecast
5.6 Nsaids
5.6.1 Market Size and Forecast
5.7 Opioids
5.7.1 Market Size and Forecast

Part 6. Global Market for Pain Management Drugs by Indication
6.1 Arthritic Pain
6.1.1 Market Size and Forecast
6.2 Cancer Pain
6.2.1 Market Size and Forecast
6.3 Chronic Pain
6.3.1 Market Size and Forecast
6.4 Fibromyalgia
6.4.1 Market Size and Forecast
6.5 Migraine
6.5.1 Market Size and Forecast
6.6 Neuropathic Pain
6.6.1 Market Size and Forecast
6.7 Post-Operative Pain
6.7.1 Market Size and Forecast

Part 8. Global Market for Pain Management Drugs by Region
8.1 Asia-Pacific
8.1.1 Market Size and Forecast
8.2 Europe
8.2.1 Market Size and Forecast
8.3 North America
8.3.1 Market Size and Forecast
8.4 Middle East And Africa (Mea)
8.4.1 Market Size and Forecast
8.5 South America
8.5.1 Market Size and Forecast

Part 8. Key Competitor Profiles
8.1 Abbott Laboratories
8.2 Eli Lily and Company
8.3 GlaxoSmithKline plc
8.4 Johnson & Johnson
8.5 Merck & Co.
8.6 Mylan N.V
8.7 Novartis International AG
8.8 Pfizer Inc.
8.9 Purdue Pharma L.P.
*LIST IS NOT EXHAUSTIVE

Part 9. Patent Analysis
9.1 Patent Statistics
9.2 Regional Analysis
9.3 Trends Analysis

DISCLAIMER
ABOUT GEN CONSULTING COMPANY